Atossa Therapeutics Announces Issuance of Key U.S. Patent Covering Endoxifen
08 mars 2022 09h15 HE
|
Atossa Therapeutics, Inc.
SEATTLE, March 08, 2022 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to develop innovative medicines in oncology and infectious...